Can I take Tessalon (benzonatate) if I am allergic to codeine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Take Tessalon Pearls if Allergic to Codeine?

Yes, you can safely take Tessalon (benzonatate) if you are allergic to codeine, as benzonatate is a peripherally acting non-opioid antitussive with a completely different mechanism of action and chemical structure from codeine, and there is no cross-reactivity between these medications.

Why Benzonatate is Safe with Codeine Allergy

Different Drug Classes and Mechanisms

  • Benzonatate is structurally related to local anesthetics (tetracaine, procaine), not opioids, and works by anesthetizing stretch receptors in the lungs to reduce the cough reflex peripherally 1, 2.

  • Codeine is a centrally acting opioid that suppresses cough through effects on the central nervous system and is metabolized by CYP2D6 into morphine 3.

  • No immunologic cross-reactivity exists between benzonatate and opioids like codeine because they belong to entirely different chemical families 4.

Clinical Evidence Supporting Safety

  • Benzonatate has been extensively studied and used for over 60 years as an effective and safe antitussive with a well-established safety profile 1, 5.

  • The American College of Chest Physicians recommends benzonatate as an effective cough suppressant option, particularly when opioid-based treatments are ineffective or contraindicated 6, 7.

  • Studies in advanced cancer patients demonstrated benzonatate's effectiveness when opioids (including codeine) were ineffective or contraindicated, confirming it as a distinct therapeutic alternative 1.

Practical Prescribing Guidance

Dosing Recommendations

  • Standard dosing is 100-200 mg three to four times daily for effective cough suppression 6, 7.

  • Capsules must be swallowed whole and never chewed or dissolved, as this can cause local anesthesia of the oral mucosa and potential serious adverse effects 2, 8.

Duration of Use

  • Limit benzonatate to short-term symptomatic relief (7-10 days for acute cough) 7.

  • If cough persists beyond 3 weeks, discontinue and reassess for underlying causes rather than continuing antitussive therapy 6.

  • For chronic bronchitis, use only for short-term symptomatic relief, not as long-term therapy 7.

Important Safety Considerations

Overdose Risk

  • Benzonatate overdose can cause rapid-onset life-threatening cardiac arrhythmias, seizures, and cardiac arrest with limited treatment options 2, 8.

  • Ingestion of as few as 10 capsules (2000 mg) has resulted in cardiac arrest and permanent neurological damage including blindness 2.

  • Patient education is critical: emphasize keeping medication away from children and never chewing capsules 2, 8.

When Benzonatate is Particularly Useful

  • Preferred first-line option for diabetic patients because it has no effect on blood glucose levels, unlike some combination cough products 6.

  • Safe in patients with porphyria with no evidence of triggering acute attacks 7.

  • Effective alternative when codeine is contraindicated due to allergy, CYP2D6 polymorphism, or concerns about opioid side effects (constipation, sedation, dependence) 6, 3.

Common Pitfalls to Avoid

  • Do not assume opioid allergy extends to benzonatate—they are unrelated drug classes with no cross-reactivity 4.

  • Do not prescribe for extended periods without reassessing the underlying cause of persistent cough 6, 7.

  • Do not use as substitute for proper diagnosis when cough becomes chronic (>8 weeks) 6.

  • Avoid prescribing large quantities due to serious overdose potential 2, 8.

References

Research

Important drugs for cough in advanced cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001

Research

Codeine: A Relook at the Old Antitussive.

The Journal of the Association of Physicians of India, 2015

Research

Genotoxicity assessment of the novel antitussive agent Benzonatate and its major metabolite.

Mutation research. Genetic toxicology and environmental mutagenesis, 2018

Guideline

Cough Management in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cough Management in Porphyria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cardiac Arrest Due to Benzonatate Overdose.

The American journal of case reports, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.